ACON

Aclarion (ACON) Jumps 3x Average Volume After USPTO Allows Key Lumbar Disc Patent

ACON (Aclarion) volume surged 3.0x average after a USPTO patent allowance for its lumbar disc evaluation tech, but -66.8% ROE flags value-trap risk in this medtech micro-cap.